APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical Excipients

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biopharmaceutical Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchBiopharmaceutical Excipients Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical Excipients Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical Excipients Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical Excipients Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Biopharmaceutical Excipients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Biopharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biopharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biopharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biopharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biopharmaceutical Excipients include BASF SE, ABITEC Corp, Colorcon, Inc, DFE Pharma, Meggle AG, Pharmonix Biological, Roquette, Sigachi Industries and Signet Chemical Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biopharmaceutical Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biopharmaceutical Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biopharmaceutical Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biopharmaceutical Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.

Biopharmaceutical Excipients Segment by Company

BASF SE

ABITEC Corp

Colorcon, Inc

DFE Pharma

Meggle AG

Pharmonix Biological

Roquette

Sigachi Industries

Signet Chemical Corporation

Spectrum Chemical Manufacturing Corp

SPI Pharma

Biopharmaceutical Excipients Segment by Type

Polyols

Carbohydrates

Solubilizers& Surfactants/Emulsifiers

Other

Biopharmaceutical Excipients Segment by Application

Biopharmaceutical Downstream

Biopharmaceutical Upstream

Biopharmaceutical Excipients Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biopharmaceutical Excipients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biopharmaceutical Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Biopharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Biopharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Biopharmaceutical Excipients Industry Trends Table 2. Biopharmaceutical Excipients Industry Drivers Table 3. Biopharmaceutical Excipients Industry Opportunities and Challenges Table 4. Biopharmaceutical Excipients Industry Restraints Table 5. Global Biopharmaceutical Excipients Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Biopharmaceutical Excipients Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Biopharmaceutical Excipients Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global Biopharmaceutical Excipients Sales Market Share by Manufacturers Table 9. Global Biopharmaceutical Excipients Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Biopharmaceutical Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Biopharmaceutical Excipients Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Biopharmaceutical Excipients Manufacturers, Product Type & Application Table 13. Global Biopharmaceutical Excipients Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Biopharmaceutical Excipients by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Polyols Table 17. Major Manufacturers of Carbohydrates Table 18. Major Manufacturers of Solubilizers& Surfactants/Emulsifiers Table 19. Major Manufacturers of Other Table 20. Global Biopharmaceutical Excipients Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 21. Global Biopharmaceutical Excipients Sales by Type (2021-2026) & (K Tons) Table 22. Global Biopharmaceutical Excipients Sales by Type (2027-2032) & (K Tons) Table 23. Global Biopharmaceutical Excipients Sales Market Share by Type (2021-2026) Table 24. Global Biopharmaceutical Excipients Sales Market Share by Type (2027-2032) Table 25. Global Biopharmaceutical Excipients Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 26. Global Biopharmaceutical Excipients Revenue by Type (2021-2026) & (K Tons) Table 27. Global Biopharmaceutical Excipients Revenue by Type (2027-2032) & (K Tons) Table 28. Global Biopharmaceutical Excipients Revenue Market Share by Type (2021-2026) Table 29. Global Biopharmaceutical Excipients Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Biopharmaceutical Downstream Table 31. Major Manufacturers of Biopharmaceutical Upstream Table 32. Global Biopharmaceutical Excipients Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 33. Global Biopharmaceutical Excipients Sales by Application (2021-2026) & (K Tons) Table 34. Global Biopharmaceutical Excipients Sales by Application (2027-2032) & (K Tons) Table 35. Global Biopharmaceutical Excipients Sales Market Share by Application (2021-2026) Table 36. Global Biopharmaceutical Excipients Sales Market Share by Application (2027-2032) Table 37. Global Biopharmaceutical Excipients Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 38. Global Biopharmaceutical Excipients Revenue by Application (2021-2026) & (K Tons) Table 39. Global Biopharmaceutical Excipients Revenue by Application (2027-2032) & (K Tons) Table 40. Global Biopharmaceutical Excipients Revenue Market Share by Application (2021-2026) Table 41. Global Biopharmaceutical Excipients Revenue Market Share by Application (2027-2032) Table 42. Global Biopharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 43. Global Biopharmaceutical Excipients Sales by Region (2021-2026) & (K Tons) Table 44. Global Biopharmaceutical Excipients Sales Market Share by Region (2021-2026) Table 45. Global Biopharmaceutical Excipients Sales Forecasted by Region (2027-2032) & (K Tons) Table 46. Global Biopharmaceutical Excipients Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Biopharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 48. North America Biopharmaceutical Excipients Sales by Country (2021-2026) & (K Tons) Table 49. North America Biopharmaceutical Excipients Sales by Country (2027-2032) & (K Tons) Table 50. Europe Biopharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 51. Europe Biopharmaceutical Excipients Sales by Country (2021-2026) & (K Tons) Table 52. Europe Biopharmaceutical Excipients Sales by Country (2027-2032) & (K Tons) Table 53. Asia Pacific Biopharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 54. Asia Pacific Biopharmaceutical Excipients Sales by Country (2021-2026) & (K Tons) Table 55. Asia Pacific Biopharmaceutical Excipients Sales by Country (2027-2032) & (K Tons) Table 56. South America, Middle East and Africa Biopharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 57. South America, Middle East and Africa Biopharmaceutical Excipients Sales by Country (2021-2026) & (K Tons) Table 58. South America, Middle East and Africa Biopharmaceutical Excipients Sales by Country (2027-2032) & (K Tons) Table 59. Global Biopharmaceutical Excipients Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Biopharmaceutical Excipients Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Biopharmaceutical Excipients Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Biopharmaceutical Excipients Revenue Market Share by Region (2021-2026) Table 63. Global Biopharmaceutical Excipients Revenue Market Share by Region (2027-2032) Table 64. BASF SE Company Information Table 65. BASF SE Business Overview Table 66. BASF SE Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. BASF SE Biopharmaceutical Excipients Product Portfolio Table 68. BASF SE Recent Development Table 69. ABITEC Corp Company Information Table 70. ABITEC Corp Business Overview Table 71. ABITEC Corp Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. ABITEC Corp Biopharmaceutical Excipients Product Portfolio Table 73. ABITEC Corp Recent Development Table 74. Colorcon, Inc Company Information Table 75. Colorcon, Inc Business Overview Table 76. Colorcon, Inc Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Colorcon, Inc Biopharmaceutical Excipients Product Portfolio Table 78. Colorcon, Inc Recent Development Table 79. DFE Pharma Company Information Table 80. DFE Pharma Business Overview Table 81. DFE Pharma Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. DFE Pharma Biopharmaceutical Excipients Product Portfolio Table 83. DFE Pharma Recent Development Table 84. Meggle AG Company Information Table 85. Meggle AG Business Overview Table 86. Meggle AG Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Meggle AG Biopharmaceutical Excipients Product Portfolio Table 88. Meggle AG Recent Development Table 89. Pharmonix Biological Company Information Table 90. Pharmonix Biological Business Overview Table 91. Pharmonix Biological Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Pharmonix Biological Biopharmaceutical Excipients Product Portfolio Table 93. Pharmonix Biological Recent Development Table 94. Roquette Company Information Table 95. Roquette Business Overview Table 96. Roquette Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Roquette Biopharmaceutical Excipients Product Portfolio Table 98. Roquette Recent Development Table 99. Sigachi Industries Company Information Table 100. Sigachi Industries Business Overview Table 101. Sigachi Industries Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Sigachi Industries Biopharmaceutical Excipients Product Portfolio Table 103. Sigachi Industries Recent Development Table 104. Signet Chemical Corporation Company Information Table 105. Signet Chemical Corporation Business Overview Table 106. Signet Chemical Corporation Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Signet Chemical Corporation Biopharmaceutical Excipients Product Portfolio Table 108. Signet Chemical Corporation Recent Development Table 109. Spectrum Chemical Manufacturing Corp Company Information Table 110. Spectrum Chemical Manufacturing Corp Business Overview Table 111. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Portfolio Table 113. Spectrum Chemical Manufacturing Corp Recent Development Table 114. SPI Pharma Company Information Table 115. SPI Pharma Business Overview Table 116. SPI Pharma Biopharmaceutical Excipients Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. SPI Pharma Biopharmaceutical Excipients Product Portfolio Table 118. SPI Pharma Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Biopharmaceutical Excipients Distributors List Table 122. Biopharmaceutical Excipients Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Biopharmaceutical Excipients Product Image Figure 2. Global Biopharmaceutical Excipients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biopharmaceutical Excipients Market Size (2021-2032) & (US$ Million) Figure 4. Global Biopharmaceutical Excipients Sales (2021-2032) & (K Tons) Figure 5. Global Biopharmaceutical Excipients Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Biopharmaceutical Excipients Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Polyols Image Figure 9. Carbohydrates Image Figure 10. Solubilizers& Surfactants/Emulsifiers Image Figure 11. Other Image Figure 12. Global Biopharmaceutical Excipients Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 13. Global Biopharmaceutical Excipients Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Biopharmaceutical Excipients Sales Market Share by Type (2021-2032) Figure 15. Global Biopharmaceutical Excipients Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 16. Global Biopharmaceutical Excipients Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Biopharmaceutical Excipients Revenue Market Share by Type (2021-2032) Figure 18. Biopharmaceutical Downstream Image Figure 19. Biopharmaceutical Upstream Image Figure 20. Global Biopharmaceutical Excipients Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 21. Global Biopharmaceutical Excipients Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Biopharmaceutical Excipients Sales Market Share by Application (2021-2032) Figure 23. Global Biopharmaceutical Excipients Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 24. Global Biopharmaceutical Excipients Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Biopharmaceutical Excipients Revenue Market Share by Application (2021-2032) Figure 26. North America Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 27. North America Biopharmaceutical Excipients Sales Market Share by Country (2021-2032) Figure 28. U.S. Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 29. Canada Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 30. Mexico Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 31. Europe Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 32. Europe Biopharmaceutical Excipients Sales Market Share by Country (2021-2032) Figure 33. Germany Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 34. France Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 35. U.K. Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. Italy Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. Netherlands Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 38. Asia Pacific Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 39. Asia Pacific Biopharmaceutical Excipients Sales Market Share by Country (2021-2032) Figure 40. China Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 41. Japan Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 42. South Korea Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. Southeast Asia Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. India Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 45. Australia Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. South America, Middle East and Africa Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 47. South America, Middle East and Africa Biopharmaceutical Excipients Sales Market Share by Country (2021-2032) Figure 48. Brazil Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 49. South Africa Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 50. Saudi Arabia Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. Turkey Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. Argentina Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 53. UAE Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. Egypt Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. Chile Biopharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Tons) Figure 56. Global Biopharmaceutical Excipients Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Biopharmaceutical Excipients Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Biopharmaceutical Excipients Revenue (2021-2032) & (US$ Million) Figure 59. North America Biopharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Biopharmaceutical Excipients Revenue (2021-2032) & (US$ Million) Figure 61. Europe Biopharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Biopharmaceutical Excipients Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Biopharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Biopharmaceutical Excipients Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Biopharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Biopharmaceutical Excipients Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Biopharmaceutical Excipients Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Polyols
  • Carbohydrates
  • Solubilizers& Surfactants/Emulsifiers
  • Other
Applications
  • Biopharmaceutical Downstream
  • Biopharmaceutical Upstream
Companies covered
  • BASF SE
  • ABITEC Corp
  • Colorcon, Inc
  • DFE Pharma
  • Meggle AG
  • Pharmonix Biological
  • Roquette
  • Sigachi Industries
  • Signet Chemical Corporation
  • Spectrum Chemical Manufacturing Corp
  • SPI Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biopharmaceutical Excipients Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biopharmaceutical Excipients Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Biopharmaceutical Excipients Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Biopharmaceutical Excipients Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Biopharmaceutical Excipients Market Dynamics
  1. 2.1 Biopharmaceutical Excipients Industry Trends
  2. 2.2 Biopharmaceutical Excipients Industry Drivers
  3. 2.3 Biopharmaceutical Excipients Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical Excipients Industry Restraints
3 Biopharmaceutical Excipients Market by Manufacturers
  1. 3.1 Global Biopharmaceutical Excipients Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Biopharmaceutical Excipients Sales by Manufacturers (2021-2026)
  3. 3.3 Global Biopharmaceutical Excipients Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Biopharmaceutical Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biopharmaceutical Excipients Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Biopharmaceutical Excipients Manufacturers, Product Type & Application
  7. 3.7 Global Biopharmaceutical Excipients Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biopharmaceutical Excipients Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biopharmaceutical Excipients Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biopharmaceutical Excipients Tier 1, Tier 2, and Tier 3
4 Biopharmaceutical Excipients Market by Type
  1. 4.1 Biopharmaceutical Excipients Type Introduction
  2. 4.1.1 Polyols
  3. 4.1.2 Carbohydrates
  4. 4.1.3 Solubilizers& Surfactants/Emulsifiers
  5. 4.1.4 Other
  6. 4.2 Global Biopharmaceutical Excipients Sales by Type
  7. 4.2.1 Global Biopharmaceutical Excipients Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Biopharmaceutical Excipients Sales by Type (2021-2032)
  9. 4.2.3 Global Biopharmaceutical Excipients Sales Market Share by Type (2021-2032)
  10. 4.3 Global Biopharmaceutical Excipients Revenue by Type
  11. 4.3.1 Global Biopharmaceutical Excipients Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Biopharmaceutical Excipients Revenue by Type (2021-2032)
  13. 4.3.3 Global Biopharmaceutical Excipients Revenue Market Share by Type (2021-2032)
5 Biopharmaceutical Excipients Market by Application
  1. 5.1 Biopharmaceutical Excipients Application Introduction
  2. 5.1.1 Biopharmaceutical Downstream
  3. 5.1.2 Biopharmaceutical Upstream
  4. 5.2 Global Biopharmaceutical Excipients Sales by Application
  5. 5.2.1 Global Biopharmaceutical Excipients Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Biopharmaceutical Excipients Sales by Application (2021-2032)
  7. 5.2.3 Global Biopharmaceutical Excipients Sales Market Share by Application (2021-2032)
  8. 5.3 Global Biopharmaceutical Excipients Revenue by Application
  9. 5.3.1 Global Biopharmaceutical Excipients Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Biopharmaceutical Excipients Revenue by Application (2021-2032)
  11. 5.3.3 Global Biopharmaceutical Excipients Revenue Market Share by Application (2021-2032)
6 Global Biopharmaceutical Excipients Sales by Region
  1. 6.1 Global Biopharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biopharmaceutical Excipients Sales by Region (2021-2032)
  3. 6.2.1 Global Biopharmaceutical Excipients Sales by Region (2021-2026)
  4. 6.2.2 Global Biopharmaceutical Excipients Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biopharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Biopharmaceutical Excipients Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Biopharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Biopharmaceutical Excipients Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Biopharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Biopharmaceutical Excipients Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Biopharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Biopharmaceutical Excipients Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Biopharmaceutical Excipients Revenue by Region
  1. 7.1 Global Biopharmaceutical Excipients Revenue by Region
  2. 7.1.1 Global Biopharmaceutical Excipients Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Biopharmaceutical Excipients Revenue by Region (2021-2026)
  4. 7.1.3 Global Biopharmaceutical Excipients Revenue by Region (2027-2032)
  5. 7.1.4 Global Biopharmaceutical Excipients Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Biopharmaceutical Excipients Revenue (2021-2032)
  8. 7.2.2 North America Biopharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Biopharmaceutical Excipients Revenue (2021-2032)
  11. 7.3.2 Europe Biopharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Biopharmaceutical Excipients Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Biopharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Biopharmaceutical Excipients Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Biopharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF SE
  2. 8.1.1 BASF SE Company Information
  3. 8.1.2 BASF SE Business Overview
  4. 8.1.3 BASF SE Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BASF SE Biopharmaceutical Excipients Product Portfolio
  6. 8.1.5 BASF SE Recent Developments
  7. 8.2 ABITEC Corp
  8. 8.2.1 ABITEC Corp Company Information
  9. 8.2.2 ABITEC Corp Business Overview
  10. 8.2.3 ABITEC Corp Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ABITEC Corp Biopharmaceutical Excipients Product Portfolio
  12. 8.2.5 ABITEC Corp Recent Developments
  13. 8.3 Colorcon, Inc
  14. 8.3.1 Colorcon, Inc Company Information
  15. 8.3.2 Colorcon, Inc Business Overview
  16. 8.3.3 Colorcon, Inc Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Colorcon, Inc Biopharmaceutical Excipients Product Portfolio
  18. 8.3.5 Colorcon, Inc Recent Developments
  19. 8.4 DFE Pharma
  20. 8.4.1 DFE Pharma Company Information
  21. 8.4.2 DFE Pharma Business Overview
  22. 8.4.3 DFE Pharma Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DFE Pharma Biopharmaceutical Excipients Product Portfolio
  24. 8.4.5 DFE Pharma Recent Developments
  25. 8.5 Meggle AG
  26. 8.5.1 Meggle AG Company Information
  27. 8.5.2 Meggle AG Business Overview
  28. 8.5.3 Meggle AG Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Meggle AG Biopharmaceutical Excipients Product Portfolio
  30. 8.5.5 Meggle AG Recent Developments
  31. 8.6 Pharmonix Biological
  32. 8.6.1 Pharmonix Biological Company Information
  33. 8.6.2 Pharmonix Biological Business Overview
  34. 8.6.3 Pharmonix Biological Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pharmonix Biological Biopharmaceutical Excipients Product Portfolio
  36. 8.6.5 Pharmonix Biological Recent Developments
  37. 8.7 Roquette
  38. 8.7.1 Roquette Company Information
  39. 8.7.2 Roquette Business Overview
  40. 8.7.3 Roquette Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Roquette Biopharmaceutical Excipients Product Portfolio
  42. 8.7.5 Roquette Recent Developments
  43. 8.8 Sigachi Industries
  44. 8.8.1 Sigachi Industries Company Information
  45. 8.8.2 Sigachi Industries Business Overview
  46. 8.8.3 Sigachi Industries Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sigachi Industries Biopharmaceutical Excipients Product Portfolio
  48. 8.8.5 Sigachi Industries Recent Developments
  49. 8.9 Signet Chemical Corporation
  50. 8.9.1 Signet Chemical Corporation Company Information
  51. 8.9.2 Signet Chemical Corporation Business Overview
  52. 8.9.3 Signet Chemical Corporation Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Signet Chemical Corporation Biopharmaceutical Excipients Product Portfolio
  54. 8.9.5 Signet Chemical Corporation Recent Developments
  55. 8.10 Spectrum Chemical Manufacturing Corp
  56. 8.10.1 Spectrum Chemical Manufacturing Corp Company Information
  57. 8.10.2 Spectrum Chemical Manufacturing Corp Business Overview
  58. 8.10.3 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Portfolio
  60. 8.10.5 Spectrum Chemical Manufacturing Corp Recent Developments
  61. 8.11 SPI Pharma
  62. 8.11.1 SPI Pharma Company Information
  63. 8.11.2 SPI Pharma Business Overview
  64. 8.11.3 SPI Pharma Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 SPI Pharma Biopharmaceutical Excipients Product Portfolio
  66. 8.11.5 SPI Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biopharmaceutical Excipients Value Chain Analysis
  2. 9.1.1 Biopharmaceutical Excipients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biopharmaceutical Excipients Production Mode & Process
  6. 9.2 Biopharmaceutical Excipients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biopharmaceutical Excipients Distributors
  9. 9.2.3 Biopharmaceutical Excipients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst